Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Ablative fractional resurfacing with laser-facilitated steroid delivery for burn scar management: Does the depth of laser penetration matter?

Issler-Fisher AC, Fisher OM, Haertsch P, Li Z, Maitz PKM.

Lasers Surg Med. 2019 Sep 30. doi: 10.1002/lsm.23166. [Epub ahead of print]

PMID:
31571242
2.

Intraoperative packed red blood cell transfusion (iPRBT) and PCI-normalised iPRBT rates (iPRBT/PCI ratio) negatively affect short- and long-term outcomes of patients undergoing cytoreductive surgery and intraperitoneal chemotherapy - An analysis of 880 patients.

Fisher OM, Alzahrani NA, Kozman MA, Valle SJ, Liauw W, Morris DL.

Eur J Surg Oncol. 2019 Jul 30. pii: S0748-7983(19)30589-X. doi: 10.1016/j.ejso.2019.07.031. [Epub ahead of print]

PMID:
31444027
3.

Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis.

Singh B, Fisher OM, Singh G, Lansom J, Bock M, Kozman M, Alzahrani N, Liauw W, Morris DL.

Ann Surg Oncol. 2019 Oct;26(11):3627-3635. doi: 10.1245/s10434-019-07510-9. Epub 2019 Jul 10.

PMID:
31292804
4.

Preoperative Nutrition Status and Postoperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Reece L, Dragicevich H, Lewis C, Rothwell C, Fisher OM, Carey S, Alzahrani NA, Liauw W, Morris DL.

Ann Surg Oncol. 2019 Aug;26(8):2622-2630. doi: 10.1245/s10434-019-07415-7. Epub 2019 May 23.

PMID:
31123932
5.

The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Shamavonian R, McLachlan R, Fisher OM, Valle SJ, Alzahrani NA, Liauw W, Morris DL.

J Gastrointest Oncol. 2019 Apr;10(2):235-243. doi: 10.21037/jgo.2018.12.11.

6.

The volume-time index (VTI) is prognostic in patients with colorectal cancer peritoneal metastases undergoing cytoreductive surgery and intraperitoneal chemotherapy.

Kozman MA, Fisher OM, Valle SJ, Alzahrani N, Liauw W, Morris DL.

Am J Surg. 2019 Apr 1. pii: S0002-9610(19)30158-8. doi: 10.1016/j.amjsurg.2019.03.023. [Epub ahead of print]

PMID:
30982572
7.

Intraoperative macroscopic tumour consistency is associated with overall survival after cytoreductive surgery and intraperitoneal chemotherapy for appendiceal adenocarcinoma with peritoneal metastases: A retrospective observational study.

Huang Y, Alzahrani NA, Fisher OM, Chua TC, Kozman MA, Liauw W, Arrowaili A, Valle SJ, Morris DL.

Am J Surg. 2019 Apr;217(4):704-712. doi: 10.1016/j.amjsurg.2018.12.037. Epub 2018 Dec 31.

PMID:
30704669
8.

An analysis of the morbidity associated with abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).

Parikh R, Shah S, Dhurandhar V, Alzahrani N, Fisher OM, Arrowaili A, Liauw W, Morris D.

Eur J Surg Oncol. 2019 Mar;45(3):394-399. doi: 10.1016/j.ejso.2018.12.020. Epub 2018 Dec 29.

PMID:
30638806
9.

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.

Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris DL; Peritoneal Surface Oncology Group International (PSOGI) and Big-RENAPE groups.

J Surg Oncol. 2019 Mar;119(3):336-346. doi: 10.1002/jso.25277. Epub 2018 Dec 16.

PMID:
30554404
10.

Rare presentation of a Bochdalek hernia in adulthood with incarcerated splenic flexure of the colon mimicking diverticulitis: a report and review.

Tan CQY, Chan DL, Chu F, Fisher OM.

ANZ J Surg. 2018 Nov 29. doi: 10.1111/ans.14945. [Epub ahead of print] No abstract available.

PMID:
30497098
11.

Surgical ultrasonography at the bedside: a comparison of surgical trainees with trained sonographers for symptomatic cholelithiasis - a first Australian experience.

Gaszynski R, Lim C, Chan DL, Fisher OM, Das KK, Merrett N, Wilson R, Cosman P.

ANZ J Surg. 2019 May;89(5):492-496. doi: 10.1111/ans.14928. Epub 2018 Nov 28.

PMID:
30484941
12.

First aid improves clinical outcomes in burn injuries: Evidence from a cohort study of 4918 patients.

Harish V, Tiwari N, Fisher OM, Li Z, Maitz PKM.

Burns. 2019 Mar;45(2):433-439. doi: 10.1016/j.burns.2018.09.024. Epub 2018 Oct 15.

PMID:
30337155
13.

Dysphagia in older persons following severe burns: Burn location is irrelevant to risk of dysphagia and its complications in patients over 75 years.

Clayton NA, Nicholls CM, Blazquez K, Brownlow C, Maitz PK, Fisher OM, Issler-Fisher AC.

Burns. 2018 Dec;44(8):1997-2005. doi: 10.1016/j.burns.2018.07.010. Epub 2018 Aug 11.

PMID:
30107942
14.

Left Paraduodenal Hernia: A Rare Complication following Laparoscopic Appendectomy.

Kozman MA, Fisher OM.

Case Rep Surg. 2017;2017:3913784. doi: 10.1155/2017/3913784. Epub 2017 Dec 6.

15.

CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.

Kozman MA, Fisher OM, Rebolledo BJ, Parikh R, Valle SJ, Arrowaili A, Alzahrani N, Liauw W, Morris DL.

J Surg Oncol. 2018 Mar;117(4):725-736. doi: 10.1002/jso.24911. Epub 2017 Dec 19.

PMID:
29266235
16.

CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.

Kozman MA, Fisher OM, Rebolledo BJ, Valle SJ, Alzahrani N, Liauw W, Morris DL.

Eur J Surg Oncol. 2017 Dec;43(12):2299-2307. doi: 10.1016/j.ejso.2017.09.009. Epub 2017 Sep 19.

PMID:
28993033
17.

Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis.

Bin Traiki TA, Fisher OM, Valle SJ, Parikh RN, Kozman MA, Glenn D, Power M, Liauw W, Alzahrani NA, Morris DL.

Eur J Surg Oncol. 2017 Oct;43(10):1939-1948. doi: 10.1016/j.ejso.2017.08.005. Epub 2017 Aug 31.

PMID:
28888800
18.

Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.

Maag JLV, Fisher OM, Levert-Mignon A, Kaczorowski DC, Thomas ML, Hussey DJ, Watson DI, Wettstein A, Bobryshev YV, Edwards M, Dinger ME, Lord RV.

Mol Cancer Res. 2017 Nov;15(11):1558-1569. doi: 10.1158/1541-7786.MCR-17-0332. Epub 2017 Jul 27.

19.

The use of carbon dioxide insufflation to facilitate identification of intestinal injuries in patients undergoing cytoreductive surgery and intraperitoneal chemotherapy.

Kozman MA, Fisher OM, Valle SJ, Alzahrani N, Morris DL.

Tech Coloproctol. 2017 Jun;21(6):479-480. doi: 10.1007/s10151-017-1644-6. Epub 2017 Jun 14. No abstract available.

PMID:
28616792
20.

Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma.

Levert-Mignon A, Bourke MJ, Lord SJ, Taylor AC, Wettstein AR, Edwards M, Botelho NK, Sonson R, Jayasekera C, Fisher OM, Thomas ML, Macrae F, Hussey DJ, Watson DI, Lord RV.

United European Gastroenterol J. 2017 Feb;5(1):13-20. doi: 10.1177/2050640616650794. Epub 2016 Jul 7.

21.

Inhibiting the system xC-/glutathione axis selectively targets cancers with mutant-p53 accumulation.

Liu DS, Duong CP, Haupt S, Montgomery KG, House CM, Azar WJ, Pearson HB, Fisher OM, Read M, Guerra GR, Haupt Y, Cullinane C, Wiman KG, Abrahmsen L, Phillips WA, Clemons NJ.

Nat Commun. 2017 Mar 28;8:14844. doi: 10.1038/ncomms14844.

22.

Interesting anatomical anomaly predisposing to gallbladder torsion.

Kozman MA, Parikh RN, Fisher OM.

ANZ J Surg. 2018 Nov;88(11):E792-E794. doi: 10.1111/ans.13830. Epub 2017 Feb 20. No abstract available.

PMID:
28219119
23.

Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis.

Liu DS, Hoefnagel SJ, Fisher OM, Krishnadath KK, Montgomery KG, Busuttil RA, Colebatch AJ, Read M, Duong CP, Phillips WA, Clemons NJ.

Oncotarget. 2016 Dec 13;7(50):83342-83358. doi: 10.18632/oncotarget.13391.

24.

Ablative fractional CO2 laser for burn scar reconstruction: An extensive subjective and objective short-term outcome analysis of a prospective treatment cohort.

Issler-Fisher AC, Fisher OM, Smialkowski AO, Li F, van Schalkwyk CP, Haertsch P, Maitz PKM.

Burns. 2017 May;43(3):573-582. doi: 10.1016/j.burns.2016.09.014. Epub 2016 Oct 1.

PMID:
27707636
25.

CD151 Gene and Protein Expression Provides Independent Prognostic Information for Patients with Adenocarcinoma of the Esophagus and Gastroesophageal Junction Treated by Esophagectomy.

Fisher OM, Levert-Mignon AJ, Lehane CW, Botelho NK, Maag JL, Thomas ML, Edwards M, Lord SJ, Bobryshev YV, Whiteman DC, Lord RV.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):746-754. Epub 2016 Aug 30.

PMID:
27577713
26.

Decreased Levels of Circulating Cancer-Associated Protein Biomarkers Following Bariatric Surgery.

Farey JE, Fisher OM, Levert-Mignon AJ, Forner PM, Lord RV.

Obes Surg. 2017 Mar;27(3):578-585. doi: 10.1007/s11695-016-2321-y.

27.

Effect of Laparoscopic Sleeve Gastrectomy on Fasting Gastrointestinal, Pancreatic, and Adipose-Derived Hormones and on Non-Esterified Fatty Acids.

Farey JE, Preda TC, Fisher OM, Levert-Mignon AJ, Stewart RL, Karsten E, Herbert BR, Swarbrick MM, Lord RV.

Obes Surg. 2017 Feb;27(2):399-407. doi: 10.1007/s11695-016-2302-1.

28.

Microbiological findings in burn patients treated in a general versus a designated intensive care unit: Effect on length of stay.

Issler-Fisher AC, Fakin RM, Fisher OM, McKew G, Gazzola R, Rauch AK, Gottlieb T, Haertsch P, Guggenheim M, Giovanoli P, Maitz PK.

Burns. 2016 Dec;42(8):1805-1818. doi: 10.1016/j.burns.2016.06.019. Epub 2016 Jun 29.

PMID:
27372144
29.

The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.

Fisher OM, Lord SJ, Falkenback D, Clemons NJ, Eslick GD, Lord RV.

Gut. 2017 Mar;66(3):399-410. doi: 10.1136/gutjnl-2015-310888. Epub 2016 Jan 5. Review.

30.

Bariatric Surgery Provides a "Bridge to Transplant" for Morbidly Obese Patients with Advanced Heart Failure and May Obviate the Need for Transplantation.

Lim CP, Fisher OM, Falkenback D, Boyd D, Hayward CS, Keogh A, Samaras K, MacDonald P, Lord RV.

Obes Surg. 2016 Mar;26(3):486-93. doi: 10.1007/s11695-015-1789-1.

PMID:
26163362
31.

Risk factors for, and the effect of MRSA colonization on the clinical outcomes of severely burnt patients.

Issler-Fisher AC, McKew G, Fisher OM, Harish V, Gottlieb T, Maitz PK.

Burns. 2015 Sep;41(6):1212-20. doi: 10.1016/j.burns.2015.03.003. Epub 2015 Jul 4.

PMID:
26150350
32.

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.

Fisher OM, Levert-Mignon AJ, Lord SJ, Lee-Ng KK, Botelho NK, Falkenback D, Thomas ML, Bobryshev YV, Whiteman DC, Brown DA, Breit SN, Lord RV.

Br J Cancer. 2015 Apr 14;112(8):1384-91. doi: 10.1038/bjc.2015.100. Epub 2015 Mar 17.

33.

An outcome and cost analysis of anal fistula plug insertion vs endorectal advancement flap for complex anal fistulae.

Fisher OM, Raptis DA, Vetter D, Novak A, Dindo D, Hahnloser D, Clavien PA, Nocito A.

Colorectal Dis. 2015 Jul;17(7):619-26. doi: 10.1111/codi.12888.

PMID:
25641401
34.

High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.

Fisher OM, Levert-Mignon AJ, Lord SJ, Botelho NK, Freeman AK, Thomas ML, Falkenback D, Wettstein A, Whiteman DC, Bobryshev YV, Lord RV.

Ann Surg Oncol. 2015 Jul;22(7):2431-8. doi: 10.1245/s10434-014-4155-y. Epub 2014 Oct 28.

Supplemental Content

Loading ...
Support Center